Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 28, Number 4—April 2022

Research

Reassessing Reported Deaths and Estimated Infection Attack Rate during the First 6 Months of the COVID-19 Epidemic, Delhi, India

Margarita Pons-SalortComments to Author , Jacob John, Oliver J. Watson, Nicholas F. Brazeau, Robert Verity, Gagandeep Kang, and Nicholas C. Grassly
Author affiliations: Imperial College London School of Public Health, London, UK (M. Pons-Salort, O.J. Watson, N.F. Brazeau, R. Verity, N.C. Grassly); Christian Medical College, Vellore, India (J. John, G. Kang)

Main Article

Figure 2

Model fit for reported coronavirus disease deaths and severe acute respiratory syndrome coronavirus 2 seroprevalence, Delhi, India, March 15–September 30, 2020. A) Model fit to the time-series of reported deaths (dots), showing 50% (darker green shading) and 95% (lighter green shading) credible intervals (CrI). The last 6 points (shown in gray) were not used for parameter inference. B) Model fit (orange dots) to seroprevalence data (gray dots) from 3 serosurveys, conducted in July, August, and September 2020, showing medians and 95% CrIs (error bars).

Figure 2. Model fit for reported coronavirus disease deaths and severe acute respiratory syndrome coronavirus 2 seroprevalence, Delhi, India, March 15–September 30, 2020. A) Model fit to the time-series of reported deaths (dots), showing 50% (darker green shading) and 95% (lighter green shading) credible intervals (CrI). The last 6 points (shown in gray) were not used for parameter inference. B) Model fit (orange dots) to seroprevalence data (gray dots) from 3 serosurveys, conducted in July, August, and September 2020, showing medians and 95% CrIs (error bars).

Main Article

Page created: January 11, 2022
Page updated: March 19, 2022
Page reviewed: March 19, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external